Skip to content

Opening book details…

About this Neuroscience article

Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients by Kantrowitz, Joshua T.; Javitt, Daniel C.; Freedman, Robert; Sehatpour, Pejman; Kegeles, Lawrence S.; Carlson, Marlene; Sobeih, Tarek; Wall, Melanie M.; Choo, Tse-Hwei; Vail, Blair; Grinband, Jack; Lieberman, Jeffrey A. is a Neuroscience article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Neuroscience.

Author
Kantrowitz, Joshua T.; Javitt, Daniel C.; Freedman, Robert; Sehatpour, Pejman; Kegeles, Lawrence S.; Carlson, Marlene; Sobeih, Tarek; Wall, Melanie M.; Choo, Tse-Hwei; Vail, Blair; Grinband, Jack; Lieberman, Jeffrey A.
Publisher
Nature Publishing Group; Springer Science and Business Media LLC; Elsevier BV; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1470-634X)
Published
2020
Field
Neuroscience (Life Sciences)

More by Kantrowitz, Joshua T.; Javitt, Daniel C.; Freedman, Robert; Sehatpour, Pejman; Kegeles, Lawrence S.; Carlson, Marlene; Sobeih, Tarek; Wall, Melanie M.; Choo, Tse-Hwei; Vail, Blair; Grinband, Jack; Lieberman, Jeffrey A.

Browse all works by Kantrowitz, Joshua T.; Javitt, Daniel C.; Freedman, Robert; Sehatpour, Pejman; Kegeles, Lawrence S.; Carlson, Marlene; Sobeih, Tarek; Wall, Melanie M.; Choo, Tse-Hwei; Vail, Blair; Grinband, Jack; Lieberman, Jeffrey A.